St. Jude Announces FDA Approval Of EnSite Precision Cardiac Mapping System

(RTTNews) - St. Jude Medical Inc. (STJ) said that the FDA has approved its EnSite Precision cardiac mapping system and Advisor FL Circular Mapping Catheter, Sensor Enabled.

The company noted that the new system enables faster, more accurate heart mapping during catheter ablation to optimize treatment for patients with abnormal heart rhythms or cardiac arrhythmias.

The new EnSite Precision cardiac mapping system is the latest addition to St. Jude's electrophysiology portfolio.

According to St. Jude Medical, the EnSite Precision cardiac mapping system is based on the company's Medical EnSite Velocity cardiac mapping system, which is utilized in more than 2,000 electrophysiology labs around the world.

The EnSite Precision cardiac mapping system introduces new solutions, including the EnSite AutoMap Module, which will enable the electrophysiologist to more quickly perform morphology matching that identifies the source of the irregular heartbeat using automated cardiac rhythm mapping tools to facilitate treatment.